Double Bond Pharmaceutical corrects release on SI053 SNO 2026 presentation, removes incorrect MAR label

Reuters2026/07/21 14:00

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Double Bond Pharmaceutical International AB issued a correction to its release on SI053 (Temodex) being accepted for presentation at the 2026 SNO Annual Meeting.
The amendment removed an incorrectly included MAR label.
The underlying announcement remains that clinical real-world evidence data for SI053 will be presented in Philadelphia on Nov. 12-15, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Double Bond Pharmaceutical International AB published the original content used to generate this news brief on July 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Double Bond Pharmaceutical corrects release on SI053 SNO 2026 presentation, removes incorrect MAR label

You may also like

Crypto prices